DAVI
Davion Healthcare Plc
Price Chart
Latest Quote
$2.94
-1.13 (-27.76%)
Current Price
| Previous Close | $4.07 |
| Open | $3.72 |
| Day High | $3.99 |
| Day Low | $2.79 |
| Volume | 217,385 |
Stock Information
| Shares Outstanding | 25.00M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $73.50M |
| EPS (TTM) | $-0.05 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
| Recommendation | none |
Technical Indicators
Performance History
| YTD | -74.76% |
| 10 Years | -74.76% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $2.94 | 217,385 |
| 2026-10-26 | $4.07 | 373,600 |
| 2026-10-23 | $6.00 | 479,500 |
| 2026-10-22 | $11.65 | 558,400 |
About Davion Healthcare Plc
Davion Healthcare Plc, a digital healthcare company, engages in the design, development, and commercialization of non-invasive health monitoring technologies. Its core consumer health portfolio comprises proprietary, home-based monitoring devices designed to support the early identification of potential medical anomalies. The company's flagship product, BreastCheck, is an FDA-registered at-home breast health screening test designed to identify potential abnormalities through changes in breast temperature. It is also developing a portfolio of proprietary health monitoring technologies, including FootFlow for monitoring indicators associated with circulation and diabetes-related blood flow issues; Testic, an at-home testicular health monitoring system; and ThermaDerm for the identification of skin anomalies, as well as technologies addressing wound monitoring, blood pressure, and other areas of preventive healthcare. The company was incorporated in 2022 and is based in Cork, Ireland.
đ° Latest News
No news articles available at the moment. Check back later for updates on DAVI.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | |||
| Total Revenue | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 |
| Expenses | |||
| Total Expenses | $1,128,807 | $1,625,183 | $5,307,686 |
| Operating Expense | $1,128,807 | $1,625,183 | $5,307,686 |
| General And Administrative Expense | $1,128,807 | $1,617,024 | $2,292,088 |
| Rent Expense Supplemental | - | $2,184 | $2,942 |
| Other Income Expense | - | $2 | $181 |
| Net Non Operating Interest Income Expense | - | $-1,007 | $-827 |
| Total Other Finance Cost | - | $1,007 | $827 |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $-1,128,807 | $-1,625,183 | $-5,308,332 |
| Normalized Income | $-1,128,807 | $-1,625,183 | $-5,308,513 |
| Net Income From Continuing And Discontinued Operation | $-1,128,807 | $-1,625,183 | $-5,308,332 |
| Total Operating Income As Reported | $-1,128,807 | $-1,625,183 | $-5,308,332 |
| Net Income Common Stockholders | $-1,128,807 | $-1,625,183 | $-5,308,332 |
| Net Income | $-1,128,807 | $-1,625,183 | $-5,308,332 |
| Net Income Including Noncontrolling Interests | $-1,128,807 | $-1,625,183 | $-5,308,332 |
| Net Income Continuous Operations | $-1,128,807 | $-1,625,183 | $-5,308,332 |
| Pretax Income | $-1,128,807 | $-1,625,183 | $-5,308,332 |
| Operating Income | $-1,128,807 | $-1,625,183 | $-5,307,686 |
| Net Interest Income | - | $-1,007 | $-827 |
| Per Share | |||
| Diluted EPS | - | $-0.70 | $-2.30 |
| Basic EPS | - | $-0.70 | $-2.30 |
| Other | |||
| Tax Effect Of Unusual Items | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-823,977 | $-1,320,353 | $-5,307,867 |
| Reconciled Depreciation | $304,830 | $304,830 | - |
| EBITDA (Bullshit earnings) | $-823,977 | $-1,320,353 | $-5,307,686 |
| EBIT | $-1,128,807 | $-1,625,183 | $-5,307,686 |
| Diluted NI Availto Com Stockholders | $-1,128,807 | $-1,625,183 | $-5,308,332 |
| Tax Provision | $0 | $0 | $0 |
| Research And Development | $0 | $8,159 | $3,015,598 |
| Selling General And Administration | $1,128,807 | $1,617,024 | $2,292,088 |
| Other Gand A | $1,128,807 | $1,617,024 | $2,289,146 |
| Total Unusual Items | - | $2 | $181 |
| Total Unusual Items Excluding Goodwill | - | $2 | $181 |
| Diluted Average Shares | - | $2,312,008 | $2,312,008 |
| Basic Average Shares | - | $2,312,008 | $2,312,008 |
| Gain On Sale Of Security | - | $2 | $181 |
| Rent And Landing Fees | - | $2,184 | $2,942 |
Fetched: 2026-10-23
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-855,584 | $-31,607 | $-5,230,917 | $122,585 |
| Total Assets | $2,325,216 | $2,497,597 | $65,001,010 | $122,585 |
| Total Non Current Assets | $2,184,618 | $2,489,448 | $65,000,000 | $0 |
| Goodwill And Other Intangible Assets | $2,184,618 | $2,489,448 | $65,000,000 | $0 |
| Other Intangible Assets | $2,184,618 | $2,489,448 | $65,000,000 | - |
| Current Assets | $140,598 | $8,149 | $1,010 | $122,585 |
| Prepaid Assets | $122,507 | $0 | $0 | $122,585 |
| Receivables | $17,033 | $8,138 | $331 | $0 |
| Taxes Receivable | $17,033 | $8,138 | $331 | $0 |
| Cash Cash Equivalents And Short Term Investments | $1,058 | $11 | $679 | $0 |
| Cash And Cash Equivalents | $1,058 | $11 | $679 | $0 |
| Debt | ||||
| Net Debt | $906,613 | - | $4,630,991 | - |
| Total Debt | $907,671 | - | $4,631,670 | - |
| Long Term Debt And Capital Lease Obligation | $907,671 | - | $4,631,670 | - |
| Long Term Debt | $907,671 | - | $4,631,670 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $996,182 | $39,756 | $5,231,927 | $0 |
| Total Non Current Liabilities Net Minority Interest | $907,671 | $0 | $4,631,670 | $0 |
| Current Liabilities | $88,511 | $39,756 | $600,257 | $0 |
| Payables And Accrued Expenses | $88,511 | $39,756 | $600,257 | $0 |
| Payables | $17,174 | $33,756 | $600,257 | - |
| Accounts Payable | $17,174 | $2,952 | $257 | $0 |
| Other Payable | - | $30,804 | $600,000 | - |
| Equity | ||||
| Common Stock Equity | $1,329,034 | $2,457,841 | $59,769,083 | $122,585 |
| Total Equity Gross Minority Interest | $1,329,034 | $2,457,841 | $59,769,083 | $122,585 |
| Stockholders Equity | $1,329,034 | $2,457,841 | $59,769,083 | $122,585 |
| Retained Earnings | $-8,316,348 | $-7,187,541 | $-5,308,332 | $0 |
| Other | ||||
| Ordinary Shares Number | $25,000,000 | $25,000,000 | $25,000,000 | $25,000,000 |
| Share Issued | $25,000,000 | $25,000,000 | $25,000,000 | $25,000,000 |
| Tangible Book Value | $-855,584 | $-31,607 | $-5,230,917 | $122,585 |
| Invested Capital | $2,236,705 | $2,457,841 | $64,400,753 | $122,585 |
| Working Capital | $52,087 | $-31,607 | $-599,247 | $122,585 |
| Total Capitalization | $2,236,705 | $2,457,841 | $64,400,753 | $122,585 |
| Additional Paid In Capital | $9,395,382 | $9,395,382 | $64,877,415 | $0 |
| Capital Stock | $250,000 | $250,000 | $200,000 | $122,585 |
| Common Stock | $250,000 | $250,000 | $200,000 | $122,585 |
| Current Accrued Expenses | $71,337 | $6,000 | $0 | $0 |
Fetched: 2026-10-23
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $-323 | $-668 | $679 |
| Operating Activities | |||
| Operating Cash Flow | $-323 | $-668 | $679 |
| Cash Flow From Continuing Operating Activities | $-323 | $-668 | $679 |
| Investing Activities | |||
| Investing Cash Flow | $0 | $0 | $0 |
| Financing Activities | |||
| Financing Cash Flow | $1,370 | $0 | $0 |
| Cash Flow From Continuing Financing Activities | $1,370 | $0 | - |
| Other | |||
| Issuance Of Debt | $1,370 | $0 | - |
| End Cash Position | $1,058 | $11 | $679 |
| Beginning Cash Position | $11 | $679 | $0 |
| Changes In Cash | $1,047 | $-668 | $679 |
| Net Issuance Payments Of Debt | $1,370 | $0 | - |
| Net Long Term Debt Issuance | $1,370 | $0 | - |
| Long Term Debt Issuance | $1,370 | $0 | - |
| Change In Working Capital | $823,654 | $1,319,685 | $5,309,011 |
| Change In Payables And Accrued Expense | $955,056 | $1,327,492 | $5,309,342 |
| Change In Payable | $955,056 | $1,327,492 | $5,309,342 |
| Change In Account Payable | $48,755 | $436,577 | $600,257 |
| Change In Prepaid Assets | $-122,507 | $0 | - |
| Change In Receivables | $-8,895 | $-7,807 | $-331 |
| Depreciation Amortization Depletion | $304,830 | $304,830 | - |
| Depreciation And Amortization | $304,830 | $304,830 | - |
| Amortization Cash Flow | $304,830 | $304,830 | - |
| Amortization Of Intangibles | $304,830 | $304,830 | - |
| Net Income From Continuing Operations | $-1,128,807 | $-1,625,183 | $-5,308,332 |
Fetched: 2026-10-23